chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Dry mouth, Somnolence
Clinical narrative: dry mouth; Diarrhea; felt sleepy/tiredness; joint aches and pain; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), DIARRHOEA (Diarrhea), SOMNOLENCE (felt sleepy/tiredness) and ARTHRALGIA (joint aches and pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced DRY MOUTH (dry mouth), DIARRHOEA (Diarrhea), SOMNOLENCE (felt sleepy/tiredness) and ARTHRALGIA (joint aches and pain). On 16-Feb-2021, ARTHRALGIA (joint aches and pain) had resolved. On 18-Feb-2021, DRY MOUTH (dry mouth) and DIARRHOEA (Diarrhea) had resolved. At the time of the report, SOMNOLENCE (felt sleepy/tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD21-034189 (E2B Linked Report).; Sender's Comments:  MOD21-034189:same reporter, husband case
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Swelling face, Temporomandibular joint syndrome
Clinical narrative: TMG sore; Earache; Swelling in face; This spontaneous case was reported by a consumer and describes the occurrence of TEMPOROMANDIBULAR JOINT SYNDROME (TMG sore), EAR PAIN (Earache) and SWELLING FACE (Swelling in face) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TEMPOROMANDIBULAR JOINT SYNDROME (TMG sore), EAR PAIN (Earache) and SWELLING FACE (Swelling in face). At the time of the report, TEMPOROMANDIBULAR JOINT SYNDROME (TMG sore), EAR PAIN (Earache) and SWELLING FACE (Swelling in face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported.  Treatment information was not provided. .
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a  and describes the occurrence of PAIN IN EXTREMITY (sore arm), TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (redness) and CHILLS (CHILLS) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (redness), CHILLS (CHILLS), PYREXIA (fever) and MYALGIA (aches and pains). At the time of the report, PAIN IN EXTREMITY (sore arm), TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (redness), CHILLS (CHILLS), PYREXIA (fever) and MYALGIA (aches and pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment details were provided.  patient does not think a follow-up is required as the reaction seems to be brought by a change in detergent.     Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: TCR Form     updated the follow-up consent of patient
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Tenderness
Clinical narrative: This spontaneous case was reported by a  and describes the occurrence of PAIN IN EXTREMITY (sore arm), TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (redness) and CHILLS (CHILLS) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (redness), CHILLS (CHILLS), PYREXIA (fever) and MYALGIA (aches and pains). At the time of the report, PAIN IN EXTREMITY (sore arm), TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (redness), CHILLS (CHILLS), PYREXIA (fever) and MYALGIA (aches and pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment details were provided.  patient does not think a follow-up is required as the reaction seems to be brought by a change in detergent.     Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: TCR Form     updated the follow-up consent of patient
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Herpes zoster, Limb discomfort, Pain in extremity, Rash
Clinical narrative: Left leg "killing patient"; Hurting at the back of left leg; Felt like a pulled muscle on left leg; Diagnosed with Shingles; Raised rash on back of left leg; Tiny bruise at injection site; A spontaneous report was received from a consumer concerning a 62 Years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events includes Developed a tiny bruise at site of injection, Patient noticed left leg was killing patient, hurting in back of leg, felt like a pulled muscle, noticed raised rash on back of left leg, Went to Urgent Care and diagnosed with Shingles  The patient's medical history was not provided. Concomitant medications used by the patient were not provided. On 30 JAN 2021, prior to the onset of the events the patient received one of two planned doses of mRNA-1273 (Batch Number Unknown) via unspecified route on her Right arm for prophylaxis of COVID-19 infection.  Treatment was done for Shingles with Valtrex. Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events was unknown and for rash it is said to be Resolving.  Patient given consent to follow-up with her
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising
Clinical narrative: Left leg "killing patient"; Hurting at the back of left leg; Felt like a pulled muscle on left leg; Diagnosed with Shingles; Raised rash on back of left leg; Tiny bruise at injection site; A spontaneous report was received from a consumer concerning a 62 Years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events includes Developed a tiny bruise at site of injection, Patient noticed left leg was killing patient, hurting in back of leg, felt like a pulled muscle, noticed raised rash on back of left leg, Went to Urgent Care and diagnosed with Shingles  The patient's medical history was not provided. Concomitant medications used by the patient were not provided. On 30 JAN 2021, prior to the onset of the events the patient received one of two planned doses of mRNA-1273 (Batch Number Unknown) via unspecified route on her Right arm for prophylaxis of COVID-19 infection.  Treatment was done for Shingles with Valtrex. Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events was unknown and for rash it is said to be Resolving.  Patient given consent to follow-up with her
Sex: F
Vaccine: COVID19
Symptoms: Cough, Vaccination site pain
Clinical narrative: Coughing; Arm ached; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing) and VACCINATION SITE PAIN (Arm ached) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm ached). On 18-Feb-2021, the patient experienced COUGH (Coughing). At the time of the report, COUGH (Coughing) and VACCINATION SITE PAIN (Arm ached) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  Treatment information include Honey cough drop.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Headache, Pain, Vomiting
Clinical narrative: body aches; Breast Pain; vomitting; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), BREAST PAIN (Breast Pain), VOMITING (vomitting) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), BREAST PAIN (Breast Pain), VOMITING (vomitting) and HEADACHE (headache). At the time of the report, PAIN (body aches), BREAST PAIN (Breast Pain), VOMITING (vomitting) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Delayed injection site reaction; injection site redness; injection site swelling; injection site itchiness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (Delayed injection site reaction), INJECTION SITE ERYTHEMA (injection site redness), INJECTION SITE SWELLING (injection site swelling) and INJECTION SITE PRURITUS (injection site itchiness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE REACTION (Delayed injection site reaction), INJECTION SITE ERYTHEMA (injection site redness), INJECTION SITE SWELLING (injection site swelling) and INJECTION SITE PRURITUS (injection site itchiness). On 30-Jan-2021, INJECTION SITE REACTION (Delayed injection site reaction) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (injection site redness), INJECTION SITE SWELLING (injection site swelling) and INJECTION SITE PRURITUS (injection site itchiness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Injection site had gotten better in the days immediately after administration but then got significantly worse on about day 7. Patient did not have any similar reactions after second dose.  No concomitant medications were reported. Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up information received on 20-Apr-2021: Event added, second dose details
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy, Peripheral swelling, Pyrexia
Clinical narrative: Swelling/lump on lower, inner arm which looks like hives possibly; Lump between her elbow and wrist - left arm - size of silver dollar; Giant lymph node reaction from the vaccine - size of quarter; Redness at injection site; Slight fever; Chills; Headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of SWELLING (Swelling/lump on lower, inner arm which looks like hives possibly), PERIPHERAL SWELLING (Lump between her elbow and wrist - left arm - size of silver dollar), LYMPHADENOPATHY (Giant lymph node reaction from the vaccine - size of quarter), VACCINATION SITE ERYTHEMA (Redness at injection site) and PYREXIA (Slight fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01322OA or 011522OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ZOLPIDEM and DOXYCYCLINE for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced SWELLING (Swelling/lump on lower, inner arm which looks like hives possibly), PERIPHERAL SWELLING (Lump between her elbow and wrist - left arm - size of silver dollar), LYMPHADENOPATHY (Giant lymph node reaction from the vaccine - size of quarter), VACCINATION SITE ERYTHEMA (Redness at injection site), PYREXIA (Slight fever), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, SWELLING (Swelling/lump on lower, inner arm which looks like hives possibly), PERIPHERAL SWELLING (Lump between her elbow and wrist - left arm - size of silver dollar), LYMPHADENOPATHY (Giant lymph node reaction from the vaccine - size of quarter), VACCINATION SITE ERYTHEMA (Redness at injection site), PYREXIA (Slight fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            Treatment for the event included extra strength Tylenol.  Action taken with mRNA-123 is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: Updated information on events received.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site erythema
Clinical narrative: Swelling/lump on lower, inner arm which looks like hives possibly; Lump between her elbow and wrist - left arm - size of silver dollar; Giant lymph node reaction from the vaccine - size of quarter; Redness at injection site; Slight fever; Chills; Headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of SWELLING (Swelling/lump on lower, inner arm which looks like hives possibly), PERIPHERAL SWELLING (Lump between her elbow and wrist - left arm - size of silver dollar), LYMPHADENOPATHY (Giant lymph node reaction from the vaccine - size of quarter), VACCINATION SITE ERYTHEMA (Redness at injection site) and PYREXIA (Slight fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01322OA or 011522OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ZOLPIDEM and DOXYCYCLINE for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced SWELLING (Swelling/lump on lower, inner arm which looks like hives possibly), PERIPHERAL SWELLING (Lump between her elbow and wrist - left arm - size of silver dollar), LYMPHADENOPATHY (Giant lymph node reaction from the vaccine - size of quarter), VACCINATION SITE ERYTHEMA (Redness at injection site), PYREXIA (Slight fever), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, SWELLING (Swelling/lump on lower, inner arm which looks like hives possibly), PERIPHERAL SWELLING (Lump between her elbow and wrist - left arm - size of silver dollar), LYMPHADENOPATHY (Giant lymph node reaction from the vaccine - size of quarter), VACCINATION SITE ERYTHEMA (Redness at injection site), PYREXIA (Slight fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            Treatment for the event included extra strength Tylenol.  Action taken with mRNA-123 is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: Updated information on events received.
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Hypokinesia, Illness
Clinical narrative: really sick; freezing; couldn't move; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (couldn't move), ILLNESS (really sick) and FEELING COLD (freezing) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00UM20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HYPOKINESIA (couldn't move) and FEELING COLD (freezing). On 18-Feb-2021 at 3:00 AM, the patient experienced ILLNESS (really sick). At the time of the report, HYPOKINESIA (couldn't move), ILLNESS (really sick) and FEELING COLD (freezing) was resolving.            No Concomitant medications were provided No Treatment information provided
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Disorientation, Insomnia, Unevaluable event
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia), CONFUSIONAL STATE (Confusion), DISORIENTATION (Disorientated) and UNEVALUABLE EVENT (Facial expression was like a stare, strange look on her face and not normal for her) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Talwin) and High cholesterol. Concomitant products included VITAMINS NOS for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced INSOMNIA (Insomnia), CONFUSIONAL STATE (Confusion), DISORIENTATION (Disorientated) and UNEVALUABLE EVENT (Facial expression was like a stare, strange look on her face and not normal for her). At the time of the report, INSOMNIA (Insomnia), CONFUSIONAL STATE (Confusion), DISORIENTATION (Disorientated) and UNEVALUABLE EVENT (Facial expression was like a stare, strange look on her face and not normal for her) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use included low dose blood pressure medication Treatment information was not provided.  The reporter confirmed that the events lasted only a few days.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: The outcome of the events were updated.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site swelling, Malaise
Clinical narrative: General malaise; Injection site Itching; Injection site swelling; Injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (General malaise), INJECTION SITE PRURITUS (Injection site Itching), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE PAIN (Injection site tenderness) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 18-Feb-2021, the patient experienced MALAISE (General malaise), INJECTION SITE PRURITUS (Injection site Itching), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE PAIN (Injection site tenderness). At the time of the report, MALAISE (General malaise), INJECTION SITE PRURITUS (Injection site Itching), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE PAIN (Injection site tenderness) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   This case was linked to MOD-2021-166690 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR: AE progress 1st dose and 2nd dose
Sex: U
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HYPOTENSION (hypotension) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced HYPOTENSION (hypotension). At the time of the report, HYPOTENSION (hypotension) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products and treatment informations were provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Nasal congestion, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Swollen lymph nodes; Chills; Slight fever; A little congestion; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), LYMPHADENOPATHY (Swollen lymph nodes), CHILLS (Chills), PYREXIA (Slight fever) and NASAL CONGESTION (A little congestion) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included Depression, Anxiety and Asthma. Concurrent medical conditions included Penicillin allergy (Allergic to Antibiotic.) and Allergy to topical drugs (Allergic to Tamiflu (Antiviral Drug)). Concomitant products included CITALOPRAM, ETHINYLESTRADIOL, NORETHISTERONE ACETATE (MICROGESTIN) and HYDROXYZINE for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), LYMPHADENOPATHY (Swollen lymph nodes), CHILLS (Chills), PYREXIA (Slight fever) and NASAL CONGESTION (A little congestion). At the time of the report, PAIN IN EXTREMITY (Sore arm), LYMPHADENOPATHY (Swollen lymph nodes), CHILLS (Chills), PYREXIA (Slight fever) and NASAL CONGESTION (A little congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: bad nose bleed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EPISTAXIS (bad nose bleed) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K2014 and 029k2074) for COVID-19 vaccination.     Concurrent medical conditions included Bronchiectasis (More coughing, increased inflammation.) since 1980, Seasonal allergy, Drug allergy, Coughing and Inflammation. Concomitant products included CELECOXIB for Arthritis, LOSARTAN POTASSIUM for Blood pressure high, NAPHAZOLINE HYDROCHLORIDE (ACONEX) from 24-Feb-2021 to an unknown date for Bone density abnormal, ATORVASTATIN for Cholesterol, CITALOPRAM for Depression and Hot flashes.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced EPISTAXIS (bad nose bleed). On 23-Jan-2021, EPISTAXIS (bad nose bleed) had resolved.            The patient reported that event stopped after nose packed with gauze.   This case was linked to MOD-2021-018400 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Patient demographics, medical history, concomitant medications and event start date updated.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested. Company assessed the event to be unlikely related to company product.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival pain, Oral pain, Rash, Toothache
Clinical narrative: Severe mouth pain; Pain in teeth; Pain in teeth; Rash on forehead; Rash on chin; This spontaneous case was reported by a nurse and describes the occurrence of ORAL PAIN (Severe mouth pain), TOOTHACHE (Pain in teeth), GINGIVAL PAIN (Pain in teeth), RASH (Rash on forehead) and RASH (Rash on chin) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025l20a) for COVID-19 immunisation.     No medical History Information Reported.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced ORAL PAIN (Severe mouth pain), TOOTHACHE (Pain in teeth), GINGIVAL PAIN (Pain in teeth), RASH (Rash on forehead) and RASH (Rash on chin). At the time of the report, ORAL PAIN (Severe mouth pain), TOOTHACHE (Pain in teeth), GINGIVAL PAIN (Pain in teeth), RASH (Rash on forehead) and RASH (Rash on chin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: a big round red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (a big round red spot at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 18-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (a big round red spot at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (a big round red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm to touch; Injection site itching; Red; Rasied; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (Rasied) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No medical history reported.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (Rasied). The patient was treated with HYDROXYZINE HCL at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (Rasied) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant products reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: An additional document received on 15 Apr 2021 included no new information
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Injection site reaction, Injection site swelling, Paraesthesia, Peripheral swelling
Clinical narrative: gone down but it still itches; arm is still itchy; delayed reaction; itching; rash; started in the same area where I had the shot; reaction to the shot almost 2 weeks later; tingling; arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (reaction to the shot almost 2 weeks later), PARAESTHESIA (tingling), PERIPHERAL SWELLING (arm is swollen), PRURITUS (gone down but it still itches) and PRURITUS (arm is still itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included VERAPAMIL, METFORMIN, LEVOTHYROXINE SODIUM (LEVOXYL), TRIAMTERENE, PRAVASTATIN, LETROZOLE, IRBESARTAN and APIXABAN (ELIQUIS) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE REACTION (reaction to the shot almost 2 weeks later), PARAESTHESIA (tingling), PERIPHERAL SWELLING (arm is swollen), ADVERSE REACTION (delayed reaction), VACCINATION SITE PRURITUS (itching), RASH (rash) and INJECTION SITE SWELLING (started in the same area where I had the shot). On 19-Feb-2021, the patient experienced PRURITUS (gone down but it still itches) and PRURITUS (arm is still itchy). At the time of the report, INJECTION SITE REACTION (reaction to the shot almost 2 weeks later), PARAESTHESIA (tingling), PERIPHERAL SWELLING (arm is swollen), PRURITUS (gone down but it still itches), PRURITUS (arm is still itchy), ADVERSE REACTION (delayed reaction), VACCINATION SITE PRURITUS (itching), RASH (rash) and INJECTION SITE SWELLING (started in the same area where I had the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site pruritus
Clinical narrative: gone down but it still itches; arm is still itchy; delayed reaction; itching; rash; started in the same area where I had the shot; reaction to the shot almost 2 weeks later; tingling; arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (reaction to the shot almost 2 weeks later), PARAESTHESIA (tingling), PERIPHERAL SWELLING (arm is swollen), PRURITUS (gone down but it still itches) and PRURITUS (arm is still itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included VERAPAMIL, METFORMIN, LEVOTHYROXINE SODIUM (LEVOXYL), TRIAMTERENE, PRAVASTATIN, LETROZOLE, IRBESARTAN and APIXABAN (ELIQUIS) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE REACTION (reaction to the shot almost 2 weeks later), PARAESTHESIA (tingling), PERIPHERAL SWELLING (arm is swollen), ADVERSE REACTION (delayed reaction), VACCINATION SITE PRURITUS (itching), RASH (rash) and INJECTION SITE SWELLING (started in the same area where I had the shot). On 19-Feb-2021, the patient experienced PRURITUS (gone down but it still itches) and PRURITUS (arm is still itchy). At the time of the report, INJECTION SITE REACTION (reaction to the shot almost 2 weeks later), PARAESTHESIA (tingling), PERIPHERAL SWELLING (arm is swollen), PRURITUS (gone down but it still itches), PRURITUS (arm is still itchy), ADVERSE REACTION (delayed reaction), VACCINATION SITE PRURITUS (itching), RASH (rash) and INJECTION SITE SWELLING (started in the same area where I had the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 02-Apr-2021. On 30-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 30-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Rapid heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid heartbeat) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Supraventricular tachycardia, Anxiety and Stress.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEART RATE INCREASED (Rapid heartbeat). At the time of the report, HEART RATE INCREASED (Rapid heartbeat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was not sure whether the side effect was due to her not having eaten, slept well, being dehydrated, stressed, or due to the vaccine itself. After she went home, ate, slept and drank some fluids, the patient's symptoms eventually went away. The patient admitted having a stressful day and she did not experience any shortness of breath. No concomitant medications reported by the patient. No treatment medications were provided.    This case was linked to MOD-2021-090310 (Patient Link).
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness, Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: muscle feels tight; arm was warm to touch; arm was itchy; 6-7-inch rash; arm was red; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), MUSCLE TIGHTNESS (muscle feels tight), VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PRURITUS (arm was itchy) and VACCINATION SITE RASH (6-7-inch rash) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroidectomy partial. Concurrent medical conditions included Drug allergy (Cipro (ciprofloxacin)), Drug allergy (Augmentin (amoxicillin/ clavulanic acid)) and Drug allergy (Cefzil (cefprozil)).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 25-Jan-2021, the patient experienced VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PRURITUS (arm was itchy), VACCINATION SITE RASH (6-7-inch rash) and VACCINATION SITE ERYTHEMA (arm was red). On 26-Jan-2021, the patient experienced MUSCLE TIGHTNESS (muscle feels tight). At the time of the report, PAIN IN EXTREMITY (arm was sore), MUSCLE TIGHTNESS (muscle feels tight), VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PRURITUS (arm was itchy) and VACCINATION SITE RASH (6-7-inch rash) outcome was unknown and VACCINATION SITE ERYTHEMA (arm was red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: muscle feels tight; arm was warm to touch; arm was itchy; 6-7-inch rash; arm was red; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), MUSCLE TIGHTNESS (muscle feels tight), VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PRURITUS (arm was itchy) and VACCINATION SITE RASH (6-7-inch rash) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroidectomy partial. Concurrent medical conditions included Drug allergy (Cipro (ciprofloxacin)), Drug allergy (Augmentin (amoxicillin/ clavulanic acid)) and Drug allergy (Cefzil (cefprozil)).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 25-Jan-2021, the patient experienced VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PRURITUS (arm was itchy), VACCINATION SITE RASH (6-7-inch rash) and VACCINATION SITE ERYTHEMA (arm was red). On 26-Jan-2021, the patient experienced MUSCLE TIGHTNESS (muscle feels tight). At the time of the report, PAIN IN EXTREMITY (arm was sore), MUSCLE TIGHTNESS (muscle feels tight), VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PRURITUS (arm was itchy) and VACCINATION SITE RASH (6-7-inch rash) outcome was unknown and VACCINATION SITE ERYTHEMA (arm was red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Injection site pain, Pain
Clinical narrative: achy; joint ache; injection site soreness; Chilling; low grade fever of 99.4F; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (achy), ARTHRALGIA (joint ache), INJECTION SITE PAIN (injection site soreness), CHILLS (Chilling) and PYREXIA (low grade fever of 99.4F) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 immunisation.     The patient's past medical history included Arthritis. Concomitant products included DICLOFENAC from 27-Jan-2021 to 27-Jan-2021 for Arthritis.   On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (achy), ARTHRALGIA (joint ache), INJECTION SITE PAIN (injection site soreness), CHILLS (Chilling) and PYREXIA (low grade fever of 99.4F). At the time of the report, PAIN (achy), ARTHRALGIA (joint ache), INJECTION SITE PAIN (injection site soreness), CHILLS (Chilling) and PYREXIA (low grade fever of 99.4F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Body temperature: 99.4 f (abnormal) The patient had a low grade fever..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: achy; joint ache; injection site soreness; Chilling; low grade fever of 99.4F; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (achy), ARTHRALGIA (joint ache), INJECTION SITE PAIN (injection site soreness), CHILLS (Chilling) and PYREXIA (low grade fever of 99.4F) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 immunisation.     The patient's past medical history included Arthritis. Concomitant products included DICLOFENAC from 27-Jan-2021 to 27-Jan-2021 for Arthritis.   On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (achy), ARTHRALGIA (joint ache), INJECTION SITE PAIN (injection site soreness), CHILLS (Chilling) and PYREXIA (low grade fever of 99.4F). At the time of the report, PAIN (achy), ARTHRALGIA (joint ache), INJECTION SITE PAIN (injection site soreness), CHILLS (Chilling) and PYREXIA (low grade fever of 99.4F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Body temperature: 99.4 f (abnormal) The patient had a low grade fever..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site nodule, Muscle spasms, Sensitive skin
Clinical narrative: Hypersensitiveness for 16 days at the COVID-arm; Muscle spasms; A bump that is growing; Redness; This spontaneous case was reported by a consumer and describes the occurrence of SENSITIVE SKIN (Hypersensitiveness for 16 days at the COVID-arm), MUSCLE SPASMS (Muscle spasms), INJECTION SITE NODULE (A bump that is growing) and INJECTION SITE ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced SENSITIVE SKIN (Hypersensitiveness for 16 days at the COVID-arm), MUSCLE SPASMS (Muscle spasms), INJECTION SITE NODULE (A bump that is growing) and INJECTION SITE ERYTHEMA (Redness). At the time of the report, SENSITIVE SKIN (Hypersensitiveness for 16 days at the COVID-arm), MUSCLE SPASMS (Muscle spasms), INJECTION SITE NODULE (A bump that is growing) and INJECTION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Red rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE RASH (Red rash at the injection site). At the time of the report, VACCINATION SITE RASH (Red rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical reported history).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching around the injection site; Patient developed red around the injection site; Swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching around the injection site ), VACCINATION SITE ERYTHEMA (Patient developed red around the injection site) and VACCINATION SITE SWELLING (Swelling around the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching around the injection site ), VACCINATION SITE ERYTHEMA (Patient developed red around the injection site) and VACCINATION SITE SWELLING (Swelling around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching around the injection site ), VACCINATION SITE ERYTHEMA (Patient developed red around the injection site) and VACCINATION SITE SWELLING (Swelling around the injection site) outcome was unknown.